BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24348476)

  • 1. NKT cells as an ideal anti-tumor immunotherapeutic.
    Fujii S; Shimizu K; Okamoto Y; Kunii N; Nakayama T; Motohashi S; Taniguchi M
    Front Immunol; 2013 Dec; 4():409. PubMed ID: 24348476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy.
    Taniguchi M; Harada M; Dashtsoodol N; Kojo S
    Proc Jpn Acad Ser B Phys Biol Sci; 2015; 91(7):292-304. PubMed ID: 26194854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer T cell activation increases iNOS
    Paul S; Chhatar S; Mishra A; Lal G
    J Immunother Cancer; 2019 Aug; 7(1):208. PubMed ID: 31387637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice.
    Shimizu K; Goto A; Fukui M; Taniguchi M; Fujii S
    J Immunol; 2007 Mar; 178(5):2853-61. PubMed ID: 17312129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Production of Functional Human NKT Cells from Induced Pluripotent Stem Cells - Reprogramming of Human Vα24
    Yamada D; Iyoda T; Shimizu K; Sato Y; Koseki H; Fujii SI
    Bio Protoc; 2017 May; 7(10):e2277. PubMed ID: 34541057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy.
    Watarai H; Yamada D; Fujii S; Taniguchi M; Koseki H
    Int J Hematol; 2012 Jun; 95(6):624-31. PubMed ID: 22592322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
    East JE; Sun W; Webb TJ
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.
    Fujii S; Shimizu K; Hemmi H; Fukui M; Bonito AJ; Chen G; Franck RW; Tsuji M; Steinman RM
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11252-7. PubMed ID: 16844772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice.
    Gebremeskel S; Clattenburg DR; Slauenwhite D; Lobert L; Johnston B
    Oncoimmunology; 2015 Mar; 4(3):e995562. PubMed ID: 25949924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.
    Duthie MS; Kahn SJ
    Immunology; 2006 Nov; 119(3):355-61. PubMed ID: 16879622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valpha14 NKT cell-mediated anti-tumor responses and their clinical application.
    Seino K; Fujii S; Harada M; Motohashi S; Nakayama T; Fujisawa T; Taniguchi M
    Springer Semin Immunopathol; 2005 Jun; 27(1):65-74. PubMed ID: 15650847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 gene transfer potentiates the alpha-galactosylceramide-stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma.
    Nishihori Y; Kato K; Tanaka M; Okamoto T; Hagiwara S; Araki N; Kogawa K; Kuribayashi K; Nakamura K; Niitsu Y
    Cancer Biol Ther; 2009 Sep; 8(18):1763-70. PubMed ID: 19901518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.
    Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y
    J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
    Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T
    J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
    Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
    Smyth MJ; Crowe NY; Pellicci DG; Kyparissoudis K; Kelly JM; Takeda K; Yagita H; Godfrey DI
    Blood; 2002 Feb; 99(4):1259-66. PubMed ID: 11830474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and activation of human Valpha24+ natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells.
    Fujii S; Shimizu K; Steinman RM; Dhodapkar MV
    J Immunol Methods; 2003 Jan; 272(1-2):147-59. PubMed ID: 12505720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.